We found that ZNF703 overexpression partially compromised the effects of SPRY4-IT1 on breast cancer proliferation (Figure 6A and 6C), whereas the knockdown of ZNF703 had the opposite effects (Figure 6B and 6D). Here, SPRY4 is linked to breast cancer.